📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021. (2022)

First Author: Ireland G

Attributed to: Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2807/1560-7917.es.2022.27.1.2101114

PubMed Identifier: 34991777

Publication URI: http://europepmc.org/abstract/MED/34991777

Type: Journal Article/Review

Volume: 27

Parent Publication: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Issue: 1

ISSN: 1025-496X